Ranbaxy recalls isotretinoin capsules in the US
This article was originally published in Scrip
Executive Summary
Ranbaxy Laboratories' US subsidiary has recalled one lot of its acne treatment, Sotret (isotretinoin) capsules 40mg, from the US market as a result of a manufacturing fault.